VAERS reports by lot

GSK Varicella/Shingles lot 97PL2: VAERS reports

55 VAERS reports list lot 97PL2 as a GSK Varicella/Shingles vaccine, received between 2020-12-01 and 2024-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1735%
Cardiac / Cardiovascular918%
Dermatological (non-injection-site)510%
Neurological48%
Allergic / Anaphylactic48%
Injection-site / Local reaction48%
Musculoskeletal36%
Gastrointestinal24%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia23
North Carolina5
Florida2
Washington1
Ohio1
Massachusetts1
Wisconsin1
Illinois1
Indiana1
South Carolina1
Idaho1
New York1

Reports by month received

2020-127
2021-012
2021-023
2021-051
2021-062
2021-081
2022-012
2023-1215
2024-017
2024-029
2024-031
2024-055

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.